NASDAQ: ESTA - Establishment Labs Holdings Inc.

Rentabilité sur six mois: -19.1%
Secteur: Healthcare

Calendrier des promotions Establishment Labs Holdings Inc.

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc.

Plus de détails
was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

Цена ао 53.54
Выручка 0.0896
EBITDA -0.0321
Число акций ао 0.0256 млрд
P/S 6.53
P/BV 14.76
EV/EBITDA -18.52
ISIN VGG312491084
Сайт https://www.establishmentlabs.com
Валюта usd
IPO date 2018-07-19
Sector Health Care
Industry Health Care Equipment & Supplies
Валюта отчета usd
Changement de prix par jour: 0% (42.53)
Changement de prix par semaine: +2.93% (41.32)
Changement de prix par mois: -3.78% (44.2)
Changement de prix sur 3 mois: -8.42% (46.44)
Changement de prix sur six mois: -19.1% (52.57)
Changement de prix par an: +14.61% (37.11)
Evolution du prix sur 3 ans: -40.27% (71.2)
Evolution du prix sur 5 ans: +104.47% (20.8)
Evolution des prix depuis le début de l'année: +69.11% (25.15)
Tous les paramètres

Sous-estimation

Nom Signification Grade
P/S 3.93 4
P/BV 35.31 1
P/E 0 0
EV/EBITDA -13.33 0
Total: 4.13

Efficacité

Nom Signification Grade
ROA, % -29.22 0
ROE, % -426.76 0
Total: 0

Dividendes

Nom Signification Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Devoir

Nom Signification Grade
Debt/EBITDA -3.15 10
Total: 8.4

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % 84.32 9
Rentabilité Ebitda, % 87.36 9
Rentabilité EPS, % 64.86 8
Total: 9.2
Plus de détails

Établissements Volume Partager, %
Nantahala Capital Management, LLC 4940308 18.16
JW Asset Management, LLC 3192485 11.73
RTW Investments LP 2494138 9.17
Brown Advisory Inc. 2428792 8.93
COWEN AND COMPANY, LLC 939948 3.46
Rice, Hall, James & Associates 750909 2.76
JP Morgan Chase & Company 747063 2.75
Morgan Stanley 673195 2.47
Findell Capital Management LLC 567000 2.08
Fourth Sail Capital LP 559003 2.05

ETF Partager, % Rentabilité pour l'année, % Dividendes, %
JPMorgan BetaBuilders U.S. Small Cap Equity Fund 0.07053 37.61291904149 1.59225
First Trust Nasdaq Lux Digital Health Solutions ETF 0.53612 40.821256038647 0.06621
iShares ESG Aware MSCI USA Small-Cap ETF 0.04619 39.294631710362 1.49366
Fidelity MSCI Health Care Index ETF 0.01273 21.181088923024 1.46057
iShares Morningstar Small-Cap ETF 0.02268 37.681332167863 1.60498
iShares Morningstar Small-Cap Growth ETF 0.04416 41.553945249597 0.72598
iShares Morningstar Small-Cap ETF 0.02268 410.50632631881 1.60498
iShares Morningstar Small-Cap Growth ETF 0.04416 757.51743375174 0.72598
Nuveen ESG Small-Cap ETF 0.01621 36.100211288862 1.41019
Simplify Health Care ETF 0.41005 34.01996408136 1.00373
SPDR Portfolio MSCI Global Stock Market ETF 0.00136 29.55850326668 2.19607



Superviseur Titre d'emploi Paiement Année de naissance
Mr. Juan Jose Chacon Quiros Founder, CEO & Executive Director 1.09M 1973 (51 année)
Mr. Rajbir Singh Denhoy Chief Financial Officer 533.2k 1971 (53 année)
Mr. S. Ross Mansbach General Counsel, Chief Compliance Officer & Chief Human Resources Officer 509.76k 1967 (57 années)
Mr. Roberto de Mezerville Chief Technology Officer N/A 1981 (43 année)
Mr. Salvador Santos Dada Head of Special Projects 468.62k 1982 (42 année)
Ms. Neeta Toprani Corporate Secretary N/A
Mr. Ivan Bilic Senior Vice President of Commercial Operations - OUS N/A
Mr. Filippo Caldini President 1965 (59 années)
Ms. Rosalyn Cole d'Incelli SVP of Global Clinical, Medical & US Regulatory Affairs
Mr. Jeff Ehrhard Senior VP & GM of North America

Adresse: Costa Rica, Alajuela, Building B15 and 25 - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.establishmentlabs.com